Clinical Trials Directory

Trials / Completed

CompletedNCT05708209

The Long Non Coding MALAT1 as a Potential Salivary Diagnostic Biomarker in Oral Squamous Cell Carcinoma Through Targeting mi RNA 124

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Fayoum University · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers

Summary

Objective: is to determine the diagnostic accuracy of lncRNA MALAT1 as a potential salivary biomarker of OSCC as well as assessment of the salivary expression level of miRNA 124 which is targeted by MALAT1. Materials and Methods: Saliva Samples were collected for the quantitative determination of salivary "MALAT1 and mi RNA -124" using quantitative Real-time Polymerase Chain Reaction technique for the two study groups, Group A: 20 patients with a diagnosis suggestive of OSCC and Group B: 20 age-and-sex-matched healthy individuals, as normal controls.

Detailed description

Materials and Methods: Saliva Samples were collected for the quantitative determination of salivary "MALAT1 and mi RNA -124" using quantitative Real-time Polymerase Chain Reaction technique for the two study groups, Group A: 20 patients with a diagnosis suggestive of OSCC and Group B: 20 age-and-sex-matched healthy individuals, as normal controls.

Conditions

Timeline

Start date
2022-11-01
Primary completion
2022-12-01
Completion
2023-01-01
First posted
2023-02-01
Last updated
2023-09-13

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05708209. Inclusion in this directory is not an endorsement.